Chemicals & Advanced Materials Global On demand · 24-48h

Global Protease Powder Market Strategic Research Report

Global Protease Powder Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Protease Powder Market
$3082025
5.2%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Microbial Fermentation Protease Powder, Animal Extract Protease Powder, Plant Extract Protease Powder

By Application: Food, Feed, Leather, Detergent, Biopharmaceutical, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Novonesis (CPH: NZYM B, Bagsværd Denmark), International Flavors & Fragrances Inc. (NYSE: IFF, New York USA), DSM-Firmenich AG (SIX: DSMF, Kaiseraugst Switzerland), Amano Enzyme Inc. (TYO: 2802, Aichi Japan), Guangdong VTR Bio-Tech Co., Ltd. (SZSE: 300381, Guangdong China), Shandong Vland Biotech Inc. (SHSE: 603739, Shandong China), AB Enzymes GmbH (Unlisted, Darmstadt Germany), Kerry Group plc (ISE: KRZ, Tralee Ireland), Advanced Enzyme Technologies Limited (NSE: ADVANZENZY, Maharashtra India), Nagase & Co., Ltd. (TYO: 8012, Tokyo Japan), Biocatalysts Ltd. (Unlisted, Wales UK), Creative Enzymes (Unlisted, New York USA), SunHY(Unlisted, Hubei China), Hunan Hongying Biological Technology Co., Ltd. (Unlisted, Hunan China), Shandong Sukahan Bio-Technology Co., Ltd. (Unlisted, Shandong China), Shandong Lonct Enzymes Co., Ltd. (Unlisted, Shandong China), Beijing Solarbio Science & Technology Co., Ltd. (Unlisted, Beijing China), Sunsonzyme (Unlisted, Beijing China), MondStar International Trading Co. Ltd (Unlisted, Henan China), Fruzyme Biotech (Unlisted, Tamil Nadu India)

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 128 pages
Market size 2025
$308
Million USD
Forecast CAGR
5.2%
2025-2032
Forecast 2032
$439.2
Projected
Gebieden
5
Asia Pacific · Latin America · MEA · Europe · North America

Overzicht

Scope of the Report

The global Protease Powder market size is predicted to grow from US$ 308 million in 2025 to US$ 437 million in 2032; it is expected to grow at a CAGR of 5.2% from 2026 to 2032.

Protease powder is a solid enzyme preparation produced through bio-fermentation, extraction, purification, and drying processes. It can efficiently catalyze protein hydrolysis reactions. Demand primarily stems from the urgent need in the feed industry (premix additives to improve animal protein digestibility), the food industry (cheese curdling, meat tenderizing, baking improvement, and protein hydrolysis), the detergent industry (powdered detergent cleaning enzymes), and the leather and textile industry (hair removal and softening agents) for standardized enzyme preparations with high stability, long shelf life, easy storage and transportation, and direct dry mixing capabilities. The upstream supply chain encompasses strain research and improvement (high-yield protease engineered strains), fermentation raw material supply (soybean meal, corn steep liquor, and other agricultural byproducts), and the manufacturing of bioreactors and drying equipment. Downstream, it directly connects with feed processing plants, food production enterprises, detergent manufacturers, leather processors, and biological reagent companies, ultimately integrating the product into various dry formulations or production processes. In 2025, protease powder production is estimated at approximately 35,000 tons, with an average price of approximately US$9,000 per ton, a gross profit margin of approximately 30%, and a single-line capacity of 400 tons per year.

Global key Protease Powder players cover Novonesis (CPH: NZYM B, Bagsværd Denmark), International Flavors & Fragrances Inc. (NYSE: IFF, New York USA), DSM-Firmenich AG (SIX: DSMF, Kaiseraugst Switzerland), Amano Enzyme Inc. (TYO: 2802, Aichi Japan), Guangdong VTR Bio-Tech Co., Ltd. (SZSE: 300381, Guangdong China), etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Protease Powder market?

What factors are driving Protease Powder market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Protease Powder market opportunities vary by end market size?

How does Protease Powder break out by Type, by Application?

This report presents a comprehensive overview of the global Protease Powder market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Microbial Fermentation Protease Powder
  • Animal Extract Protease Powder
  • Plant Extract Protease Powder

Segment by Enzymatic Properties

  • Acid
  • Neutral
  • Alkaline

Segment by Application

  • Food
  • Feed
  • Leather
  • Detergent
  • Biopharmaceutical
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Protease Powder market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Food, Feed, Leather evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Protease Powder Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.2%
Regional growth momentum
Market share by segment
Key metrics
Base value
$308
2025
Forecast
$439.2
2032
CAGR
5.2%
2025–2032
Gebieden
5
global
Key companies
Novonesis (CPH: NZYM BBagsværd Denmark)International Flavors & Fragrances Inc. (NYSE: IFFNew York USA)DSM-Firmenich AG (SIX: DSMFKaiseraugst Switzerland)Amano Enzyme Inc. (TYO: 2802Aichi Japan)
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Microbial Fermentation Protease PowderAnimal Extract Protease PowderPlant Extract Protease Powder
By Application
FoodFeedLeatherDetergentBiopharmaceuticalOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Microbial Fermentation Protease Powder
  • 3.1.3 Animal Extract Protease Powder
  • 3.1.4 Plant Extract Protease Powder
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Food
  • 4.1.3 Feed
  • 4.1.4 Leather
  • 4.1.5 Detergent
  • 4.1.6 Biopharmaceutical
  • 4.1.7 Other
  • 4.1.8 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Novonesis (CPH: NZYM B, Bagsværd Denmark)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 International Flavors & Fragrances Inc. (NYSE: IFF, New York USA)
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 DSM-Firmenich AG (SIX: DSMF, Kaiseraugst Switzerland)
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Amano Enzyme Inc. (TYO: 2802, Aichi Japan)
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Guangdong VTR Bio-Tech Co., Ltd. (SZSE: 300381, Guangdong China)
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Shandong Vland Biotech Inc. (SHSE: 603739, Shandong China)
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 AB Enzymes GmbH (Unlisted, Darmstadt Germany)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Kerry Group plc (ISE: KRZ, Tralee Ireland)
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Advanced Enzyme Technologies Limited (NSE: ADVANZENZY, Maharashtra India)
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Nagase & Co., Ltd. (TYO: 8012, Tokyo Japan)
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Biocatalysts Ltd. (Unlisted, Wales UK)
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Creative Enzymes (Unlisted, New York USA)
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 SunHY(Unlisted, Hubei China)
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Hunan Hongying Biological Technology Co., Ltd. (Unlisted, Hunan China)
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Shandong Sukahan Bio-Technology Co., Ltd. (Unlisted, Shandong China)
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Shandong Lonct Enzymes Co., Ltd. (Unlisted, Shandong China)
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Beijing Solarbio Science & Technology Co., Ltd. (Unlisted, Beijing China)
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Sunsonzyme (Unlisted, Beijing China)
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 MondStar International Trading Co. Ltd (Unlisted, Henan China)
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Fruzyme Biotech (Unlisted, Tamil Nadu India)
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Protease Powder market?
The global Protease Powder market is estimated at US$ 308 million in 2025 (base year) and is projected to reach US$ 437 million by 2032.
What is the forecast CAGR for the Protease Powder market?
The market is expected to grow at a CAGR of 5.2% from 2026 to 2032, expanding from US$ 308 million in 2025 to US$ 437 million in 2032, roughly 1.4 times its base-year value.
What is Protease Powder?
Protease powder is a solid enzyme preparation produced through bio-fermentation, extraction, purification, and drying processes. It can efficiently catalyze protein hydrolysis reactions.
What are the main segments of the Protease Powder market by type?
By type, the market is segmented into Microbial Fermentation Protease Powder, Animal Extract Protease Powder and Plant Extract Protease Powder.
Which applications drive demand in the Protease Powder market?
Key applications covered include Food, Feed, Leather, Detergent, Biopharmaceutical and Other.
Who are the key players in the Protease Powder market?
Key players profiled include Novonesis (CPH: NZYM B, Bagsværd Denmark), International Flavors & Fragrances Inc. (NYSE: IFF, New York USA), DSM-Firmenich AG (SIX: DSMF, Kaiseraugst Switzerland), Amano Enzyme Inc. (TYO: 2802, Aichi Japan), Guangdong VTR Bio-Tech Co., Ltd. (SZSE: 300381, Guangdong China), Shandong Vland Biotech Inc. (SHSE: 603739, Shandong China), AB Enzymes GmbH (Unlisted, Darmstadt Germany) and Kerry Group plc (ISE: KRZ, Tralee Ireland), among 20 companies covered in total.
Which regions and countries are covered for Protease Powder?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Protease Powder market?
What factors are driving Protease Powder market growth, globally and by region?
Who should buy the Protease Powder market report?
The report is intended for manufacturers and solution providers, distributors and end users in Food, Feed and Leather, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Protease Powder market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.